Bright Minds Biosciences Inc banner

Wall St Price Targets

DRUG Price Forecast
No price targets yet

We don't have analyst price targets for DRUG yet.

DRUG Analyst Rating
Based on 9 analysts

avg. 4.89 of 5
Strong buy
8 89%
Buy
1 11%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate DRUG Strong buy, with 9 of 9 recommending Buy or Strong buy.

Bright Minds Biosciences Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DRUG's stock price target?
Not Available

DRUG does not have any price targets made by Wall Street professionals.

Back to Top